Tat Ka Wai Hong Pharmaceutical Industry Group Co., Ltd. (SHE:301126)
China flag China · Delayed Price · Currency is CNY
9.02
+0.13 (1.46%)
Oct 28, 2026, 4:00 PM EDT

SHE:301126 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Revenue
5,0525,1445,2333,9043,2922,592
Revenue Growth
-6.11%-1.70%34.07%18.56%27.01%10.79%
Gross Profit
971.3932.121,036568.05391.68300.35
Operating Income
91.5483.14196.75122.61108.23128.3
Net Income
-237.77-242.4626.5734.351.0868.26
Earnings Per Share
-1.16-1.180.130.170.250.44
EPS Growth
---23.53%-32.00%-43.18%4.76%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Dec '21
Pharmaceutical Distribution
1,9602,2142,3012,2761,880
Pharmaceutical Retail
2,9422,6921,505993.4691.07
Hospital income
10.6614.4112.779.4514.77
Drug production revenue
215.15299.8475.85--
Other Income
16.8613.338.43--
Total
5,1445,2333,9043,2922,592

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Investments
303.16596.55619.85649.4643748.07
Total Debt
3,4023,6723,2862,5741,610753.41
Net Cash (Debt)
-3,098-3,075-2,666-1,925-967.4-5.34
Net Cash Growth
------
Net Cash Per Share
-15.08-14.97-13.04-9.54-4.73-0.03

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Cash Flow
-43.5-149.1224.0427.13-493.96-161.81
Capital Expenditures
-71.6-104.63-187.14-226.7-208.73-33.29
Free Cash Flow
-115.1-253.75-163.1-199.57-702.69-195.1
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Gross Margin
19.23%18.12%19.80%14.55%11.90%11.59%
Operating Margin
1.81%1.62%3.76%3.14%3.29%4.95%
Pretax Margin
-4.25%-4.28%1.45%1.24%2.31%3.70%
Profit Margin
-4.71%-4.71%0.51%0.88%1.55%2.63%
FCF Margin
-2.28%-4.93%-3.12%-5.11%-21.34%-7.53%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Dividend Per Share
0.1040.0220.0820.0400.0290.034
Dividend Per Share Growth
0%-73.11%104.50%37.93%-14.71%-
Dividend Yield
1.15%0.18%0.78%0.31%0.19%0.15%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
PE Ratio
--80.6978.4560.2068.65
PS Ratio
0.370.490.410.690.931.81